Skin epidermal and superficial dermal proteins and cells

Skin epidermal and superficial dermal proteins and cells represent a complex anatomical and functional target area rather than a single molecular entity. The epidermis, primarily composed of keratinocytes, provides a vital physical and immunological barrier, while the superficial (papillary) dermis contains fibroblasts, collagen, and microvasculature (Yousef et al., 2023). In clinical pharmacology, this designation is frequently cited in the context of topical therapies and photodynamic treatments where drugs like aminolevulinic acid are metabolized into photosensitizers within these specific layers (Agostinis et al., 2011). Therapeutic interventions aimed at this region typically address conditions such as actinic keratosis, non-melanoma skin cancers, and inflammatory dermatoses (Mayo Clinic, 2023). Because this designation encompasses a wide array of proteins (e.g., keratins, collagen) and cell types (e.g., melanocytes, Langerhans cells), it lacks the specificity of a traditional molecular drug target (Chambers & Vukmanovic-Stejic, 2020). Consequently, it is often used to describe the localized site of action for physical or chemical modalities that affect the cutaneous microenvironment.

Other names

Epidermis and papillary dermisCutaneous cellular and protein matrixSkin layersEpidermal and dermal cells

Topical agents and photodynamic therapies target these layers to induce selective cytotoxicity in dysplastic cells, modulate local immune responses via Toll-like receptors, or inhibit DNA synthesis in hyperproliferative tissues.